 |
 |
 |
 |
 |
 |
|
||||||||||||||
SELECT PUBLICATIONS
Chien AJ, Goss PE. Aromatase inhibitors and bone health in women with breast cancer. J Clin Oncol 2006;24(33):5305-12. No abstract available
Felson DT, Cummings SR. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum 2005;52(9):2594-8. No abstract available
Goss PE et al. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. J Clin Oncol 2007;25(15):2006-11. Abstract
Kennecke HF et al. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen. Ann Oncol 2007;18(1):45-51. Abstract
Perez EA et al. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: A companion study to NCIC CTG MA.17. J Clin Oncol 2006;24(22):3629-35. Abstract
Rocca WA et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007a;69(11):1074-83. Abstract
Rocca WA et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2007b;[Epub ahead of print]. Abstract
| Table of Contents | Top of Page |
